Corporate Executive Team

Sir Andrew Witty - Chief Executive Officer

Sir Andrew Witty became Chief Executive Officer of GlaxoSmithKline plc in May 2008 after joining the Board in January 2008.
Find out more about Sir Andrew Witty

Simon Bicknell - Senior Vice President, Governance, Ethics and Assurance

Simon Bicknell assumed the role of Senior Vice President, Governance, Ethics and Assurance in January 2011.
Find out more about Simon Bicknell

John Clarke

John Clarke was President, Consumer Healthcare until October 2011 when he handed over to Emma Walmsley. John will step down as a member of CET in March 2012.
Find out more about John Clarke

Deirdre Connelly - President, North American Pharmaceuticals

Deirdre Connelly assumed the role of President, North American Pharmaceuticals in February 2009.
Find out more about Deirdre Connelly

Simon Dingemans - Chief Financial Officer

Marc Dunoyer - Head of Rare Diseases Unit and Chairman of GSK Japan

Marc Dunoyer was appointed Chairman of GSK Japan in January 2010 and assumed the role of Head of Rare Diseases Unit in February 2010.
Find out more about Marc Dunoyer

Eddie Gray - President, Pharmaceuticals Europe

Eddie Gray assumed the role of President, Pharmaceuticals Europe in January 2008.
Find out more about Eddie Gray

Abbas Hussain - President, Emerging Markets & Asia Pacific

Abbas Hussain assumed the role of President, Emerging Markets & Asia Pacific in June 2008.
Find out more about Abbas Hussain

Bill Louv - Senior Vice President, Core Business Services & Chief Information Officer

Bill Louv assumed the role of Chief Information Officer in January 2007. In addition he was appointed to create and lead Core Business Services in April 2010.
Find out more about Bill Louv

David Pulman - President, Global Manufacturing and Supply

David Pulman assumed the role of President, Global Manufacturing and Supply in December 2002.
Find out more about David Pulman

David Redfern - Chief Strategy Officer

David Redfern assumed the role of Chief Strategy Officer in May 2008 and was also appointed Chairman of ViiV Healthcare in April 2011.
Find out more about David Redfern

Moncef Slaoui - Chairman, Research & Development

Moncef Slaoui became Chairman, Research & Development, GlaxoSmithKline plc in June 2006 after joining the Board in April 2006.
Find out more about Moncef Slaoui

Jean Stéphenne - Chairman and President, Biologicals

Jean Stéphenne assumed the role of Chairman and President , Biologicals in 1998.
Find out more about Jean Stéphenne

Claire Thomas - Senior Vice President, Human Resources

Claire Thomas assumed the role of Senior Vice President, Human Resources in May 2008.
Find out more about Claire Thomas

Phil Thomson - Senior Vice President, Global Communications

Phil Thomson assumed the role of Senior Vice President, Global Communications in August 2010.
Find out more about Phil Thomson

Dan Troy - Senior Vice President & General Counsel

Dan Troy assumed the role of Senior Vice President and General Counsel in September 2008.
Find out more about Dan Troy

Patrick Vallance - Senior Vice President, Medicines Discovery and Development

Patrick Vallance assumed the role of Senior Vice President, Medicines Discovery and Development in July 2010.
Find out more about Patrick Vallance

Emma Walmsley - President, Consumer Healthcare Worldwide

Emma Walmsley assumed the role of President, Consumer Healthcare Worldwide in October 2011.
Find out more about Emma Walmsley